A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

Influenza Virus Clinical Trial

Official title:
A Phase 2a, Randomized, Double-Blind,Placebo-Controlled Study to Investigate the Effects of VX-787 Administered to Adult Volunteers Experimentally Inoculated With Live Influenza Virus

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the antiviral activity and safety of VX-787 given to healthy adult volunteers that have been inoculated with the influenza virus.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01561807
Study type	Interventional
Source	Vertex Pharmaceuticals Incorporated
Contact
Status	Completed
Phase	Phase 2
Start date	March 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00998803` - Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults	N/A
Completed	`NCT00760175` - Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients	N/A
Completed	`NCT01964989` - Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.	Phase 3
Recruiting	`NCT05375006` - Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant Culture